Finally Bristol Myers Squib receives approval from EU for Idecabtagene Vicleucel... May 23
CABENUVA reduces treatment dosing days from 365 to 12 per year ​... Mar 21
Dr. Nayak started his career as a physician in Bangalore, India and has an MBA in Marketing. He joined Takeda in 2011 and, since then, ... Feb 26
An accomplished scientific leader and industry veteran with over 25 years of experience in small molecule pharmaceutical process and product development, Dean Edney will split ... Feb 20
The app converts sign language into audible speech using deep neural networks... Jan 27
To this end, the Board of Trustees of GMU headed by Dr. Thumbay Moideen, Founder and President, recently appointed Prof. Sherief Khalifa, the Dean of ... Jan 15
Concord,a Lupin alliance partner gets another approval... Dec 20
-Advertisements-
Monday, May 13, 2024
.jpeg)
